ApniCure

ApniCure is a private Redwood City, Calif.-based medical device company focused on developing and commercializing novel home-use devices incorporating a proprietary platform technology called Oral Pressure Therapy (OPT) for the treatment of obstructive sleep apnea (OSA) and other sleep related disorders. ApniCure has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Winx® Sleep Therapy System in the United States for home-use treatment of OSA. The Winx system is the first in a series of products that ApniCure plans to introduce. ApniCure aims to improve the lives of the millions of patients suffering from sleep disordered breathing, by providing them with quality, innovative, effective sleep therapies.
Type
Private
HQ
Redwood City, US
Founded
2007
Employees
25 (est)-3%
ApniCure was founded in 2007 and is headquartered in Redwood City, US

Key People at ApniCure

Lawrence Siegel

Lawrence Siegel

Chief Medical Officer
Dan George

Dan George

Vice President of Finance
Chris Daniel

Chris Daniel

Executive Vice President of Operations, Founder
Glen French

Glen French

President and CEO
Jed Crowe

Jed Crowe

Director, Research and Development, Founder
Jonathan Podmore

Jonathan Podmore

Vice President of Research and Development, Founder

ApniCure Locations

Redwood City, US

ApniCure Metrics

ApniCure Summary

Founding Date

2007

Total Funding

$20.9 M

Latest funding size

$15.8 M

Time since last funding

9 months

Investors

ApniCure's latest funding round of $15.8 M was in March 2016. In total, ApniCure has raised $20.9 M.
19% of current employees of ApniCure are female and 81% are male.

ApniCure Company Life

You may also be interested in